Summary
Guardant Health, Inc. (GH) filed an 8-K on November 4, 2021, to report its financial results for the fiscal quarter ended September 30, 2021. The core of this filing is the press release (Exhibit 99.1) containing these financial details. Investors should note that the information furnished in this report is not considered 'filed' for the purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities as a standard filing, nor is it automatically incorporated into other SEC filings unless specifically referenced. This is a common practice for earnings press releases attached to 8-Ks. While the specific financial figures are detailed in the press release furnished as an exhibit, the 8-K itself serves as the formal notification mechanism. Investors looking for concrete performance metrics such as revenue, net income/loss, earnings per share, and any forward-looking guidance will need to refer to Exhibit 99.1. The filing also includes the Cover Page Interactive Data File in XBRL format, aiding in data extraction and analysis.
Key Highlights
- 1Guardant Health announced its third quarter 2021 financial results on November 4, 2021, via an 8-K filing.
- 2The press release containing the detailed financial results for the quarter ended September 30, 2021, is furnished as Exhibit 99.1.
- 3The filing explicitly states that the furnished information is not deemed 'filed' under Section 18 of the Exchange Act.
- 4This means the information is provided for informational purposes and does not incur the same level of liability as formally filed information.
- 5Investors must consult Exhibit 99.1 for specific financial performance data and any management commentary on results.
- 6The filing also includes the Cover Page Interactive Data File (XBRL) for data accessibility.